Meet the W&D Committee


Amanda Brown, Ph.D.

http://www.hopkinsmedicine.org/neurology_neurosurgery/research/JHU_NIMH/researchers/profiles/abrown.html

Dr. Brown received her doctoral training at the Albert Einstein College of Medicine, in Bronx, New York. She is an Assistant Professor in the Department of Neurology at the Johns Hopkins University School of Medicine. Dr. Brown’s research is focused on identifying and studying key cellular pathways that modulate HIV-1 replication in marophages and exploring their impact on the development of HIV-associated neurocognitive disorder.


 


Pranoti-Mandrekar.jpg PRANOTI MANDREKAR, Ph.D.

http://profiles.umassmed.edu/profiles/display/130975
 

Associate Professor in the Department of Medicine, 2011-Present, Co-Director of the Translational Science program, Graduate School of Biomedical Sciences at University of Massachusetts Medical School (UMASS), 2012-Present. Research Interests: Mechanisms of activation and signaling pathways in innate immune cells; Cytokines and Chemokines in liver injury, fibrosis and cancer; Translational and pre-clinical research in liver diseases; Cellular stress responses and crosstalk with immune activation pathways; Toll-like receptor pathways and inflammation in steatohepatitis; Host defense and inflammation.


Vijaya Iragavarapu-Charyulu, Ph.D.

http://www.fau.edu

Dr. Iragavarapu-Charyulu received her doctoral training at University of Miami, Miami, Forida and her postdoctoral training at Mount Sinai MCenter, New York, USA and at University of Miami, Miami, Florida, USA. She is a tenured Associate Professor at Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida. Dr. Iragavarapu's research centers on the role of inflammation and immune response in breast cancer. More specifically, she is studying the roinflammatory chemokines, MMPs and chitinase-3-like-1 molecule on tumor-host interactions in breast cancer.



 


CheriƩ L. Butts, Ph.D.

Dr. Butts conducts research and serves as a reviewer for drug and biologic products in the Division of Therapeutic Proteins at the Center for Drug Evaluation & Research of the US Food & Drug Administration. She obtained her undergraduate and master's degrees at The Johns Hopkins University and her PhD from UT MD Anderson Cancer Center/UT Health Sciences Center at Houston. Her graduate studies focused on studying immune responses in ovarian cancer patients with metastatic disease and characterizing immunity at tumor sites. Dr. Butts continued her training as a postdoctoral fellow at the National Institutes of Health exploring the role of steroid hormones in regulating immune responses, and her current work investigates the impact of steroid hormones on immunity during disease development in an effort to develop better strategies for driving potent anti-tumor immune responses. Dr. Butts also teaches and mentors students interested in biomedical  research careers.


Kimberly Dyer, Ph.D.
kdyer@niaid.nih.gov
http://www.niaid.nih.gov/LabsAndResources/labs/aboutlabs/lad/eosinophilBiologySection/Pages/dyer.aspx


Dr. Kimberly Dyer is a staff scientist in the Eosinophil Biology Section (EBS) of the Laboratory of Allergic Diseases/NIAID at the National Institutes of Health. She has a BS from Virginia Tech, a MS from The Johns Hopkins University and received her doctorate from Georgetown University. Dr. Dyer is interested in the differentiation, development and biology of eosinophils. She has developed a method for generating eosinophils from unselected mouse bone marrow in large numbers and high purity that has greatly facilitated eosinophil research worldwide. Dr. Dyer is a member of the American Association of Immunologist, the American Society of Cell Biology, the International Eosinophil Society as well as the Society of Leukocyte Biology.


Christine A. Biron, Ph.D.
christine_biron@brown.edu

https://vivo.brown.edu/display/cbiron

Brintzenhoff Professor and former Chairperson in the Department of Molecular Microbiology and Immunology, focuses her research on innate immunity to viruses, particularly at the level of natural killer cells, cytokines, and signal transducers and activators of transcription. She trained at UMASS, UNC, and Scripps Research Foundation, and was a Visiting Scientist at the Karolinska Institute as well as a Visiting Professor at Trinity College Dublin. A past Scholar of the Leukemia Society of American, she has served as Associate Editor for the Journal of Immunology, on the Editorial Board for Virology, on NIH Study Sections, on the Board of Scientific Counselors of the NCI, and on the US-Japan Immunology Board for NIAID. She currently serves in editorial capacities on mBio, The Journal of Experimental Medicine, Frontiers in Immunology, and Immunity.  She is on the External Scientific Advisory Board for the Trudeau Institute, and on the Board of Scientific Counselors of the NIAID. Professor biron is an elected Fellow of both the American Association for the Advancement of Science and the American Academy of Microbiology.